Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

14.21 -0.02 (-0.11%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Iovance's Update Provides Reassurance With Upcoming Lifileucel's FDA Action Date, Analyst Says ↗

July 10, 2023

Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced regulatory and clinical updates related to its registrational single-arm Phase 2 IOV-LUN-202 trial in post-anti-PD-1

Via Benzinga

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 10, 2023

Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...

Via Benzinga

Why Iovance Biotherapeutics (IOVA) Shares Are Exploding Higher ↗

July 10, 2023

Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher by 14.3% to $8.28 Monday morning after the company announced regulatory, clinical updates for TIL therapy in

Via Benzinga

Analyst Ratings for Iovance Biotherapeutics ↗

June 15, 2023

Via Benzinga

Analyst Expectations for Iovance Biotherapeutics's Future ↗

May 30, 2023

Via Benzinga

What's Going On With Iovance Biotherapeutics Stock? ↗

May 30, 2023

Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher Tuesday after the U.S.

Via Benzinga

Where Iovance Biotherapeutics Stands With Analysts ↗

May 30, 2023

Via Benzinga

Iovance Biotherapeutics Announces Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer

July 10, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

June 29, 2023

Via Benzinga

Iovance Biotherapeutics to Host Virtual Roundtable with Key Opinion Leaders to Discuss Melanoma Treatment Landscape

June 20, 2023

Investor Conference Call and Webcast on June 26 at 5:00 p.m. ET

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

How to Trade Stocks Online the Right Way

June 13, 2023

Learning how active trading works requires serious education, including learning how to get started. Learn how to trade stocks online on MarketBeat.

Via MarketBeat

Analyst Ratings for Iovance Biotherapeutics ↗

May 10, 2023

Via Benzinga

Recap: Iovance Biotherapeutics Q1 Earnings ↗

May 09, 2023

Via Benzinga

Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon ↗

April 20, 2023

These two biotech stocks might be significantly undervalued.

Via The Motley Fool

Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference

June 09, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2 ↗

June 02, 2023

Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics.

Via Talk Markets

Why Shares of Iovance Biotherapeutics Jumped Tuesday ↗

May 30, 2023

The company received approval for a biologics license application for an advanced melanoma therapy.

Via The Motley Fool

Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application

May 30, 2023

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Admin

Via MarketBeat

Topics Death

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 30, 2023

Via Benzinga

Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter...

Via Benzinga

Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

May 30, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Gaotu Techedu Inc. (NYSE: GOTU) shares jumped 19.7% to $2.98 in pre-market...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 29, 2023

Via Benzinga

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

May 26, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Ulta Beauty, Tilray Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 26, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Iovance Biotherapeutics Reports First Quarter 2023 Financial Results and Corporate Updates

May 09, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, May 9, 2023

May 02, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Shares of Iovance Biotherapeutics Jumped Monday ↗

May 01, 2023

The stock bounced back big from its 52-week low last week.

Via The Motley Fool

Iovance Biotherapeutics to Present at Upcoming Conferences

April 24, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Shares of Iovance Biotherapeutics Jumped Monday ↗

March 27, 2023

The company filed a Biologics License Application to the FDA for its lead therapy.

Via The Motley Fool

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.